ResMed (RMD) Proxy Filing summary

Executive summary

• Annual meeting scheduled for Nov. 20, 2024, at 4:30 p.m. U.S. Pacific Time; Nov. 21 at 8:30 a.m. Singapore Time and 11:30 a.m. Australian Eastern Time, with virtual participation.

• Shareholders are asked to elect directors, ratify the auditor and cast an advisory say-on-pay vote.

Voting matters and shareholder proposals

• Three ballot matters: election of 11 directors, ratification of KPMG LLP for FY ending June 30, 2025, and advisory approval of named executive officer compensation.

• The board recommends voting For each of the 11 director nominees, auditor ratification and say-on-pay.

Board of directors and corporate governance

• Eleven nominees—Carol Burt, Christopher DelOrefice, Jan De Witte, Karen Drexler, Michael Farrell, Peter Farrell, Harjit Gill, John Hernandez, Richard Sulpizio, Desney Tan and Ronald Taylor—are proposed to serve until the 2025 annual meeting and until successors are elected and qualified.